ClinicalTrials.Veeva

Menu
C

Chatham-Kent Clinical Trials Research Centre | Chatham, Canada

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BI 409306
BI 425809
Donepezil
SPD489
Brexpiprazole
Lisdexamfetamine Dimesylate
Troriluzole
JNJ-55308942
Vortioxetine
PF-05212377

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 11 total trials

Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder

The study's purpose its to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compu...

Enrolling
Obsessive-Compulsive Disorder
Drug: Troriluzole
Drug: Placebo

The purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compuls...

Invitation-only
Obsessive Compulsive Disorder
Drug: Troriluzole (BHV-4157)

Trial sponsors

Boehringer Ingelheim logo
Biohaven logo
Janssen (J&J Innovative Medicine) logo
Lundbeck logo
Otsuka logo
Pfizer logo
Purdue Pharma logo
Shire logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems